Sign In
Buy CLOV
$4.27
-0.0600 (-1.39%)
At Close: Aug 04, 2026
Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization
09:00am, Tuesday, 07'th Jan 2025
WILLMINGTON, Del., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), an AI-powered physician enablement platform, today announced it has successfully deployed its Counter
4 MedTech Stocks That Gained More Than 100% in 2024 With Room to Run
11:56am, Monday, 23'rd Dec 2024
Here are some strong MedTech stocks - DOCS, CLOV, CLPT and HIMS - that are expected to provide promising gains.
Recent Earnings Disappointment Could Be An Ideal Buying Opportunity For Clover Health
02:35am, Saturday, 21'st Dec 2024
Clover Health's recent performance shows mixed results, with revenue growth but a significant share price drop, presenting a potential buying opportunity. Operational efficiency is improving, with bet
Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
04:05pm, Tuesday, 17'th Dec 2024
JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced t
Clover Health: Balancing Innovation And Challenges
07:19am, Wednesday, 11'th Dec 2024
Clover Health Investments shows financial progress and challenges in 2024, with a focus on innovative Medicare Advantage plans and technology-driven healthcare solutions. The company achieved a 4.0 ra
Here's Why Clover Health Investments (CLOV) Could be Great Choice for a Bottom Fisher
10:55am, Thursday, 05'th Dec 2024
After losing some value lately, a hammer chart pattern has been formed for Clover Health Investments (CLOV), indicating that the stock has found support. This, combined with an upward trend in earning
5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025
09:01am, Wednesday, 04'th Dec 2024
Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.
Clover Health: Buy The Dip, Reap The Rewards
11:50am, Monday, 18'th Nov 2024
Clover's 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Clover continues to grow its topline and improve its bottom line performance. Clover's latest star rating upgra
Down -26.32% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround
10:36am, Friday, 15'th Nov 2024
Clover Health Investments (CLOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street anal
Down -25.82% in 4 Weeks, Here's Why Clover Health Investments (CLOV) Looks Ripe for a Turnaround
10:35am, Thursday, 14'th Nov 2024
The heavy selling pressure might have exhausted for Clover Health Investments (CLOV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now
10:56am, Tuesday, 12'th Nov 2024
After losing some value lately, a hammer chart pattern has been formed for Clover Health Investments (CLOV), indicating that the stock has found support. This, combined with an upward trend in earning
CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised
12:20pm, Thursday, 07'th Nov 2024
Clover Health's third-quarter 2024 results continue to benefit from the strength of its business model.
Clover Health Investments, Corp. (CLOV) Reports Q3 Loss, Lags Revenue Estimates
07:26pm, Wednesday, 06'th Nov 2024
Clover Health Investments, Corp. (CLOV) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.09 per share a year ago.
Clover Health Investments, Corp. (CLOV) Q3 2024 Earnings Call Transcript
06:50pm, Wednesday, 06'th Nov 2024
Clover Health Investments, Corp. (NASDAQ:CLOV ) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer
Clover Health's Rally: The Payoff Of A Profitable Pivot
03:41am, Wednesday, 06'th Nov 2024
Clover Health's pivot to profitability over growth following the divestiture of the non-insurance segment at the end of 2023 has led to significant earnings improvements. The newly launched Counterpar
